Kapural, L., Mekhail, N., Hayek, S. M., Stanton-Hicks, M., & Malak, O. (2005, August). Occipital nerve electrical stimulation via the midline approach and subcutaneous surgical leads for treatment of severe occipital neuralgia: A pilot study. Anesthesia & Analgesia , 101 (1), 171-174. Retrieved from https:///profile/Nagy_Mekhail/publication/7767938_Occipital_Nerve_Electrical_Stimulation_via_the_Midline_Approach_and_Subcutaneous_Surgical_Leads_for_Treatment_of_Severe_Occipital_Neuralgia_A_Pilot_Study/links/53f1f1270cf272810e4c785d/Occipital-Nerve-Electrical-Stimulation-via-the-Midline-Approach-and-Subcutaneous-Surgical-Leads-for-Treatment-of-Severe-Occipital-Neuralgia-A-Pilot-
The prognosis (outcome) for cancer patients may range from excellent to poor. The prognosis is directly related to both the type and stage of the cancer. For example, many skin cancers can be completely cured by removing the skin cancer tissue; similarly, even a patient with a large tumor may be cured after surgery and other treatments like chemotherapy (note that a cure is often defined by many clinicians as a five-year period with no reoccurrence of the cancer). However, as the cancer type either is or becomes aggressive, with spread to lymph nodes or is metastatic to other organs, the prognosis decreases. For example, cancers that have higher numbers in their staging (for example, stage III or T3N2M1; see staging section above) have a worse prognosis than those with low (or 0) numbers. As the staging numbers increase, the prognosis worsens and the survival rate decreases.
Dermatologic: alopecia, urticaria, skin rashes, toxic epidermal necrolysis, erythema multiforme, erythema nodosum, fixed drug eruption, lichen planus, pustular reaction, systemic lupus erythematoses, bullous reactions, including Stevens-Johnson syndrome, photosensitive dermatitis, photosensitivity reactions, including rare cases resembling porphyria cutanea tarda (pseudoporphyria) or epidermolysis bullosa. If skin fragility, blistering or other symptoms suggestive of pseudoporphyria occur, treatment should be discontinued and the patient monitored.